SummitTX Capital L.P. Acquires Shares of 2,647 Cigna Group $CI

SummitTX Capital L.P. acquired a new stake in shares of Cigna Group (NYSE:CI) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 2,647 shares of the health services provider’s stock, valued at approximately $706,000.

A number of other institutional investors have also made changes to their positions in the company. Wilkerson Advisory Group LLC purchased a new stake in Cigna Group during the 4th quarter worth $25,000. Kemnay Advisory Services Inc. purchased a new position in Cigna Group in the 4th quarter valued at about $29,000. Prosperity Bancshares Inc purchased a new position in Cigna Group in the 4th quarter valued at about $29,000. Cedar Mountain Advisors LLC grew its stake in shares of Cigna Group by 161.9% during the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares in the last quarter. Finally, Lodestone Wealth Management LLC acquired a new stake in shares of Cigna Group during the fourth quarter valued at about $32,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Price Performance

CI opened at $287.56 on Friday. The firm has a market cap of $76.07 billion, a price-to-earnings ratio of 12.19, a price-to-earnings-growth ratio of 1.14 and a beta of 0.29. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $315.47. The company’s 50-day moving average price is $286.75 and its 200 day moving average price is $281.12. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 EPS for the quarter, beating analysts’ consensus estimates of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The company had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. During the same period in the previous year, the firm posted $7.20 earnings per share. Cigna Group’s quarterly revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts expect that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. Cigna Group’s payout ratio is currently 26.45%.

Insider Buying and Selling

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares in the company, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This trade represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna reported second-quarter adjusted earnings of $7.78 per share, above the roughly $7.58–$7.60 analyst consensus and up from $7.20 a year earlier. Total revenue rose 7% year over year to approximately $71.7 billion. Cigna Q2 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its 2026 adjusted income-from-operations outlook to at least $30.45 per share, modestly above the previous outlook and analyst expectations. Growth across both Cigna Healthcare and Evernorth Health Services supported the increase. Cigna raises annual profit forecast
• Positive Sentiment: Cigna Healthcare adjusted revenue increased 9%, while Evernorth revenue rose 6%, indicating broad-based operating momentum. The company also repurchased about $250 million of stock year to date through July 29. The Cigna Group Reports Strong Second Quarter 2026 Results
• Neutral Sentiment: Cigna posted quarterly net income of nearly $1.7 billion, or $6.29 per share, but reported revenue slightly below the consensus estimate in some measures, highlighting the importance of adjusted results and segment growth.
• Negative Sentiment: Investors remain concerned about elevated pharmacy costs and management’s expectation for slower growth in prescriptions for popular GLP-1 drugs, which could limit near-term benefit from the fast-growing treatment category. Cigna Expects Lower Growth in GLP-1 Prescriptions
• Negative Sentiment: Reported data also shows significant insider selling during the past six months, including sales by Chairman and CEO David Cordani. While these transactions may reflect personal portfolio decisions, they can weigh on investor sentiment.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Wells Fargo & Company boosted their price target on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research note on Friday, May 1st. Piper Sandler lowered their price objective on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a research note on Wednesday, June 3rd. Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and dropped their price objective for the stock from $310.00 to $304.00 in a report on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and cut their target price for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. Finally, Robert W. Baird set a $337.00 price target on shares of Cigna Group in a research report on Friday, May 1st. One research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.